VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE · Real-Time Price · USD
0.3806
-0.0323 (-7.82%)
Oct 10, 2025, 12:11 PM EDT - Market open

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Chronic Inflammatory and Immune-mediated Therapies
501.00K
Log In
Log In
Log In
Log In
Upgrade
Chronic Inflammatory and Immune-mediated Therapies Growth
18.16%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
United States
501.00K
Log In
Log In
Log In
Log In
Upgrade
United States Growth
18.16%
Log In
Log In
Log In
Log In
Upgrade